Gland Pharma Ltd
₹2940.20
as on
What are INDmoney investors doing with Gland Pharma shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-49%
Searches for Gland Pharma on INDmoney have decreased by 49% over the last 30 days.
Investment activity on INDmoney
-79.79%
Investment activity in Gland Pharma among INDmoney users has decreased by 79.79% over the last 30 days.
Among the most traded stocks
262nd
Gland Pharma was the 262nd most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
13 days
INDmoney investors hold Gland Pharma shares for an average of 13 days.
Key Events for Gland Pharma
Gland Pharma Stock Performance
as on September 21, 2026 at 9:31 pm IST
Day's Low
Day's High
₹2,916.20₹3,008.00
0.82%
Downside
2.31%
Upside
52 Week's Low
52 Week's High
₹1,573.60₹3,042.0046.48%
Downside
3.46%
Upside
Gland Pharma share price movements today
- Previous Close
- ₹2,961.90
- Open
- ₹2,965.00
- Volume
- 2.79L
- Upper Circuit
- ₹3,554.20
- Lower Circuit
- ₹2,369.60
- Day's Low - High
- ₹2,916.20 - ₹3,008.00
- 52 Week Low - High
- ₹1,573.60 - ₹3,042.00
Gland Pharma Historical Returns
- 1 Month Return
- + 5.06 %
- 3 Month Return
- + 35.45 %
- 1 Year Return
- + 47.01 %
- 3 Year Return
- + 74.76 %
- 5 Year Return
- -23.36 %
Gland Pharma Fundamentals
as on September 21, 2026 at 4:01 pm IST
Market Cap
₹48,874.56 Cr
Return on Equity (ROE)
12.64
PE Ratio (TTM)
43.23
Return on capital employed (ROCE)
17.11
Industry PE ratio
51.88
Beta (LTM)
0.58
P/B Ratio
2.59
Dividend Yield
1.18
PEG Ratio
1.99
Quarterly Earnings Growth YOY
47.09
EPS (TTM)
62.35
Book Value
628.67
Gland Pharma Stock Valuation
as on September 21, 2026 at 4:01 pm IST
Gland Pharma in the last 5 years
Lowest (18.84x)
May 22, 2023
Today (43.23x)
September 18, 2026
Industry (51.88x)
September 18, 2026
Highest (67.14x)
August 12, 2021
Today’s Price to Earnings Ratio: 43.23x
Gland Pharma Technical Analysis
Track how Gland Pharma technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -1.92 | |
CCI (20) | 238.16 | |
RSI (14) | 38.63 | Neutral |
Momentum (10) | -2.8 | |
ADI (14) | 32.84 | |
Ultimate Oscillator (7,14,28) | 22.21 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 2940.67 | |
EMA (20) | 2939.61 | |
VWMA (20) | 2938.73 | |
SMA (50) | 2942.97 | |
EMA (50) | 2941.82 | |
SMA (200) | 2948.42 | |
EMA (200) | 2948.23 | |
KAMA (200) | 2943.57 | |
DEMA (200) | 2940.77 |
Gland Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Gland Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 48,874.56 | -4.67% | 0.52 | 1,027 | 6,430 | |
| BUY | 2,48,876.79 | 16.2% | 0.52 | 2,568 | 10,560 | |
| BUY | 1,84,098.04 | 43.61% | 0.87 | 2,138 | 19,274 | |
| HOLD | 62,743.22 | 0.97% | 0.68 | 37 | 2,346 | |
| BUY | 1,12,655.86 | 9.17% | 0.52 | 3,869 | 39,011 |
Market expectation of Gland Pharma Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
73.33%
Buy
6.67%
Hold
20.00%
Sell
Gland Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Gland Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Gland Pharma Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Gland Pharma
Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Gland Pharma
Sorted by largest increase in holding, month-over-month.
Fund Name | Value of Holding | Increase (MoM) | Holding % |
|---|---|---|---|
 SBI Large & Midcap Fund Direct Growth | ₹936.92 Cr | ₹4.15 Cr (+0.45%) | 2.17% |
Mutual Funds Exiting Gland Pharma
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
 Mirae Asset Large & Midcap Fund Direct Plan Growth | ₹574.78 Cr | ₹98.45 Cr (-14.62%) | 1.23% |
Gland Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Gland Pharma.
Gland Pharma Ltd Earnings Results
Gland Pharma Ltd’s net profit jumped 47.09% since last year same period to ₹316.96Cr in the Q1 2026-2027. On a quarterly growth basis, Gland Pharma Ltd has generated -13.56% fall in its net profits since last 3-months.
Read More about Earnings ResultsGland Pharma Ltd Dividends May,2026
In the quarter ending March 2026, Gland Pharma Ltd has declared dividend of ₹20.00 per share on 15 May 2026 - translating a dividend yield of 0.68%.
Read More about Dividends
Indices Featuring Gland Pharma Stock
Check stock indices that include Gland Pharma.
Insights on Gland Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 7.30% to 8.74% in Jun 2026 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, GLAND stock has moved up by 35.5%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 7 quarters, 1.44K Cr → 1.86K Cr (in ₹), with an average increase of 4.1% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 7.52% to 9.05% in Jun 2026 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 158.2% return, outperforming this stock by 83.5%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 53.9% return, outperforming this stock by 6.9%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 31.78% to 28.23% in Jun 2026 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 366.68 Cr → 316.96 Cr (in ₹), with an average decrease of 13.6% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 51.83% to 51.77% in Jun 2026 quarter
About Gland Pharma Ltd
Gland Pharma's operations include the development, manufacture, and marketing of a wide range of injectable drugs and active pharmaceutical ingredients. The company's product portfolio includes antibiotics, anti-emetics, anti-diabetics, anti-epileptics, and other therapeutic categories. Its top products include cephalosporins, penicillins, and other injectable antibiotics.
Gland Pharma is well known for its popular brands, such as Cephalosporin, Penicillin, and Amikacin. These brands have been widely used in hospitals and clinics across India, as well as in other countries. In addition, the company has developed and launched a wide range of generic and branded injectables, including Cefazolin, Cefuroxime, and Amikacin.
Revenue: ₹1,800.27Cr as on June 2026 (Q1 FY27)
Net Profit: ₹316.96Cr as on June 2026 (Q1 FY27)
Listing date: 20 Nov, 2020
Chairperson Name: Yiu Kwan Stanley Lau
| Organisation | Gland Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Yiu Kwan Stanley Lau |
| E-voting on shares | Click here to vote |
FAQs
What is Gland Pharma share price today?
Gland Pharma share price today stands at ₹2940.2 as on at the close of the market. Gland Pharma share today touched a day high of ₹3008 and a low of ₹2916.2.
What is the 52 week high and 52 week low range for Gland Pharma share?
Gland Pharma touched a 52 week high of ₹3042 and a 52 week low of ₹1573.6. Gland Pharma share price today i.e. is closed at ₹2940.2, which is -3.35% down from its 52 week high and 86.85% up from its 52 week low.
What is Gland Pharma's market capitalisation today?
Gland Pharma market capitalisation is ₹48,874.56 Cr as on .
How to buy Gland Pharma shares?
To buy Gland Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for GLAND or Gland Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Gland Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Gland Pharma trading volume today?
Gland Pharma trading volume is 2.79L as on . This means that 2.79L shares of Gland Pharma were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Gland Pharma shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Gland Pharma have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 13 days. This reflects platform activity only and is not investment advice.